Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) Study

Abstract

Sildenafil added to conventional treatment reduces RV mass and improves cardiac function and exercise capacity in patients with PAH, WHO functional class III. Safety monitoring is important until more experience is obtained.